Clinical Trials Browser

Gallbladder Neoplasms, Cholangiocarcinoma

Anus Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Gastric Adenocarcinoma

Lung Neoplasms

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Breast Neoplasms, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Endometrial Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Hypopharyngeal Neoplasms

Pancreatic Neoplasms

Hepatic Artery Infusion

Esophageal Squamous Cell Carcinoma

Gastroesophageal Junction Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

Salivary Gland Neoplasms

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Pancreatic Adenocarcinoma

Pancreatic Neoplasms

Biliary Tract Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Breast Neoplasms

Adenocarcinoma, Pancreatic Neoplasms

Pancreatic Neoplasms, Neoplasms, Basal Cell

Triple Negative Breast Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Pancreatic Adenocarcinoma

Pancreatic Neoplasms

Stomach Neoplasms

Advanced Solid Tumor

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

HER2-negative Breast Cancer

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Muscle-Invasive Bladder Carcinoma

Advanced or Metastatic Solid Tumors

Head and Neck Neoplasms, Lung Neoplasms

Ovarian Neoplasms, Recurrence

HER2 Positive Advanced Solid Tumors

Locally Advanced Cervical Cancer

Esophageal Squamous Cell Carcinoma

Lymphoma, Neoplasm Metastasis, Recurrence

Locally Advanced or Metastatic Solid Tumors

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

PANCREAS

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

G/GEJ

LAP100

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy

Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Folfox+Irinotecan+Chemort In Esophageal Cancer

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

ATRiBRAVE

Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

PANGEA

Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC

PURITY

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer

Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer

Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC

Chemoradiotherapy in Unresectable Esophageal Cancer

Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC

ORIENTA

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

CNN-BC

Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors

ATATcH Alternating Treatment Plans for Advanced Cancer

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC